Molecular etiology of cervicovaginal adenosis by in utero hormone exposure
Molecular etiology of cervicovaginal adenosis by in utero hormone exposure
批准号:
8099471
负责人:
Takeshi Kurita
金额:
$30.69万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2015-04-30
关键词:
1-Phosphatidylinositol 3-KinaseActivinsAdenocarcinomaBMP4BenignBindingBinding SitesBiological AssayBone Morphogenetic ProteinsCell LineCervicalCervix UteriCervix carcinomaClear CellColumnar CellDevelopmentDiethylstilbestrolDiseaseDuctal EpitheliumEarly DiagnosisEndocrine DisruptorsEnvironmentEpithelialEpitheliumEstrogensEtiologyExcisionExocervixExposure toGenesGlandular CellGoalsHeterochromatinHormonesHuman PapillomavirusHuman papilloma virus infectionIn VitroIncidenceKnockout MiceKnowledgeLeadLesionMesenchymeMolecularMusMutationPIK3CA genePTEN genePathogenesisPerinatal ExposurePregnant WomenRecording of previous eventsRegulationReporterReportingRiskRisk FactorsRoleSignal PathwaySignal TransductionSquamous EpitheliumStructure of paramesonephric ductSystemTestingThyroid Hormone ReceptorThyroid HormonesTriiodothyronineTumor Suppressor ProteinsUterusVaginaVaginal AdenocarcinomaWomanactivin Achromatin remodelingembryonic stem cellenvironmental chemicalimprovedin uteroinhibitor/antagonistmouse modeloverexpressionpromoterprotein complexpublic health relevancetranscription factorxenoestrogen
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The ultimate goal of this study is to elucidate the molecular mechanisms of cervical and vaginal adenosis development and its progression to adenocarcinoma. Cervical and vaginal adenosis is a congenital anomaly defined as the presence of columnar (tall) glandular cells in normally squamous (flat) epithelium of ectocervix and vagina. Cervical/vaginal adenosis has been studied in the context of cervical/vaginal clear cell adenocaricinoma (CCAC) associated with in utero exposure to a synthetic estrogen diethylstilbestrol (DES). Women exposed to DES in utero are at increased risk of developing CCAC, which is believed to arise from preexisting adenosis lesions. Although incidences have declined significantly after DES use for pregnant women was banned in 1971, cervical/vagina adenosis and CCAC are still reported in women without history of DES exposure, suggesting that there are other factors that contribute to these conditions in the environment. Using a mouse model, we have previously demonstrated that developmental exposure to DES induces cervical/vaginal adenosis by disrupting expression of p63 transcription factor, which is essential for development of squamous epithelia. To elucidate the pathogenesis of cervical/vaginal adenosis, we propose to study signaling mechanism that induces p63 expression in developing cervical/vaginal epithelium, and how developmental exposure to estrogen and thyroid hormone disrupts this signaling. Primarily, we will study how p63 promoter is developmentally regulated using mouse model and reporter assay system with cell line. In addition, we also propose to study progression of adenosis to adenocarcinoma. The cervical and vaginal CCACs are generally negative for human papilloma virus (HPV) infection, and their etiology is not understood. Recently, high incidence of mutations in PIK3Ca or PTEN gene resulting in uncontrolled-activation of PI3K (phosphatidylinositol-3 kinase) signaling has been reported in CCACs of cervix. Therefore, we will explore whether uncontrolled-activation of PI3K signaling transforms adenosis into adenocarcinoma using double knockout mouse model for p63 and Pten tumor suppressor. The knowledge obtained from this study will help us identify potential risk factors that exist in our environment for cervical/vaginal adenosis. In addition, by studying molecular etiology of HPV-negative cervical/vaginal adenocarcinoma, it may lead to early detection and discovery of a new and improved treatment for this disease.
PUBLIC HEALTH RELEVANCE: Although adenocarcinomas of ectocervix and vagina are believed to arise from preexisting benign adenosis lesions, its etiology is unknown. This project will identify the risk factor (e.g. environmental chemicals) for adenosis and adenocarcinoma of ectocervix and vagina by elucidating the molecular pathogenesis of these conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Xenograft Study on Growth-Control of Human Uterine Leiomyomata
-
批准号:8839966
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2014
-
负责人:Takeshi Kurita
-
依托单位:
Molecular Etiology of Cervicovaginal Adenosis by in Utero Hormone Exposure
-
批准号:8840386
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2014
-
负责人:Takeshi Kurita
-
依托单位:
Core B: Tissue Procurement and Cell Culture Core
-
批准号:8308003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Takeshi Kurita
-
依托单位:
Xenograft Study on Growth-Control of Human Uterine Leiomyomata
-
批准号:8644820
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2010
-
负责人:Takeshi Kurita
-
依托单位:
Molecular etiology of cervicovaginal adenosis by in utero hormone exposure
-
批准号:8259786
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2010
-
负责人:Takeshi Kurita
-
依托单位:
Xenograft Study on Growth-Control of Human Uterine Leiomyomata
-
批准号:7849337
-
项目类别:
-
资助金额:$40.74万
-
财政年份:2010
-
负责人:Takeshi Kurita
-
依托单位:
Xenograft Study on Growth-Control of Human Uterine Leiomyomata
-
批准号:8447118
-
项目类别:
-
资助金额:$29.52万
-
财政年份:2010
-
负责人:Takeshi Kurita
-
依托单位:
Xenograft Study on Growth-Control of Human Uterine Leiomyomata
-
批准号:8050043
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2010
-
负责人:Takeshi Kurita
-
依托单位:
Xenograft Study on Growth-Control of Human Uterine Leiomyomata
-
批准号:8241149
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2010
-
负责人:Takeshi Kurita
-
依托单位:
Molecular etiology of cervicovaginal adenosis by in utero hormone exposure
-
批准号:8470473
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2010
-
负责人:Takeshi Kurita
-
依托单位:
Core B: Tissue Procurement and Cell Culture Core
-
批准号:7752689
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Takeshi Kurita
-
依托单位:
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer
-
批准号:9257202
-
项目类别:
-
资助金额:$34.04万
-
财政年份:--
-
负责人:Takeshi Kurita
-
依托单位:
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer
-
批准号:8829689
-
项目类别:
-
资助金额:$33.03万
-
财政年份:--
-
负责人:Takeshi Kurita
-
依托单位:
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer
-
批准号:9036866
-
项目类别:
-
资助金额:$33.12万
-
财政年份:--
-
负责人:Takeshi Kurita
-
依托单位:
Core B: Tissue Procurement and Cell Culture Core
-
批准号:8099642
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Takeshi Kurita
-
依托单位:
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer
-
批准号:8510775
-
项目类别:
-
资助金额:$33.04万
-
财政年份:--
-
负责人:Takeshi Kurita
-
依托单位:
Project 3: Medically-based Protection of the Ovarian Reserve Against Anti-Cancer
-
批准号:8642668
-
项目类别:
-
资助金额:$32.28万
-
财政年份:--
-
负责人:Takeshi Kurita
-
依托单位:
海外基金